Stock listing

OTC:SMNR Semnur Pharmaceuticals, Inc. Stock

Follow Semnur Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · OTC:SMNR

$0.15 USD -0.10 (-40.0%)

Close on Nov 20, 2026 · Data provided by Twelve Data

Past year -98.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.10 – $0.25 USDNov 20, 2026
Volume
30,969 sharesNov 20, 2026
52-week range
$0.10 – $23.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2,857 USDMedian day 4,142 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Semnur Pharmaceuticals, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:SMNR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.15-0.10-40.0%$0.25$0.25$0.1030,969
$0.25+0.05+25.0%$0.136$0.30$0.1365,135
$0.20-0.01-4.8%$0.36$0.36$0.1529,450
$0.21-0.14-40.0%$0.36$0.36$0.1580,186
$0.35-0.12-25.5%$0.34$0.47$0.303,321
$0.47+0.14+42.4%$0.48$0.48$0.295,409
$0.33+0.03+10.0%$0.49$0.49$0.334,125
$0.300.000.0%$0.49$0.49$0.302,893
$0.30-0.01-3.2%$0.50$0.50$0.301,810
$0.31+0.01+3.3%$0.50$0.50$0.295,474
$0.300.000.0%$0.30$0.50$0.3011,723
$0.30-0.13-30.2%$0.30$0.30$0.302,520
$0.43-0.035-7.5%$0.43$0.50$0.306,523
$0.465+0.165+55.0%$0.50$0.50$0.434,614
$0.30-0.058-16.2%$0.50$0.50$0.302,514
$0.358+0.038+11.9%$0.30$0.50$0.302,258
$0.32+0.02+6.7%$0.50$0.50$0.325,588
$0.30-0.20-40.0%$0.30$0.32$0.301,193
$0.50-0.01-2.0%$0.52$0.52$0.2910,500
$0.51+0.01+2.0%$0.366$0.52$0.366872
$0.50+0.124+33.0%$0.38$0.52$0.3663,588
$0.3760.000.0%$0.376$0.376$0.376372
$0.376-0.024-6.0%$0.366$0.376$0.3661,469
$0.40-0.027-6.3%$0.40$0.40$0.36610,327
$0.427+0.027+6.7%$0.427$0.427$0.4271,016
$0.40-0.115-22.3%$0.51$0.52$0.388772
$0.515+0.139+37.0%$0.525$0.525$0.3761,245
$0.376-0.007-1.8%$0.535$0.535$0.3662,590
$0.383-0.044-10.3%$0.488$0.488$0.3665,147
$0.427-0.113-20.9%$0.427$0.427$0.4271,899
$0.54+0.12+28.6%$0.56$0.56$0.2913,189
$0.420.000.0%$0.42$0.43$0.424,496
$0.42-0.001-0.1%$0.575$0.575$0.4064,158
$0.421-0.029-6.6%$0.575$0.575$0.411,046
$0.450.000.0%$0.128$0.57$0.1286,104
$0.45-0.12-21.1%$0.45$0.575$0.453,552
$0.57+0.014+2.5%$0.45$0.57$0.453,678
$0.556-0.014-2.4%$0.49$0.575$0.4514,901
$0.57+0.012+2.2%$0.49$0.575$0.492,555
$0.558-0.041-6.9%$0.45$0.575$0.454,742
$0.599+0.136+29.5%$0.128$0.615$0.1284,765
$0.4630.000.0%$0.61$0.65$0.4633,174
$0.463-0.067-12.7%$0.61$0.61$0.463614
$0.53+0.08+17.8%$0.463$0.61$0.4636,058
$0.450.000.0%$0.466$0.466$0.451,793
$0.45-0.01-2.2%$0.45$0.61$0.452,064
$0.46+0.01+2.2%$0.45$0.46$0.45618
$0.45-0.16-26.2%$0.61$0.61$0.454,802
$0.61+0.11+22.0%$0.50$0.61$0.453,380
$0.500.000.0%$0.51$0.51$0.508,188
$0.500.000.0%$0.61$0.61$0.503,520
$0.50-0.05-9.1%$0.67$0.67$0.505,827
$0.55-0.01-1.8%$0.56$0.56$0.555,475
$0.56+0.059+11.9%$0.55$0.57$0.552,133
$0.501-0.05-9.0%$0.50$0.68$0.504,010
$0.55+0.000.0%$0.55$0.68$0.551,645
$0.550.000.0%$0.50$0.60$0.505,444
$0.550.000.0%$0.55$0.60$0.553,878
$0.550.000.0%$0.50$0.60$0.503,954
$0.55-0.03-5.2%$0.55$0.58$0.5510,018
$0.58-0.04-6.5%$0.62$0.62$0.5627,334
$0.62+0.01+1.6%$0.75$0.75$0.606,105
$0.61-0.01-1.6%$0.62$0.63$0.6012,401
$0.62-0.05-7.5%$0.67$0.80$0.6222,484
$0.67+0.000.0%$0.67$0.68$0.678,442
$0.67-0.15-18.2%$0.66$0.80$0.6258,639
Ticker
OTC:SMNR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Semnur Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
Decks
9 decks · latest September 2024

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
2.31

Team and board

Officers

OfficerRole
Henry JiExecutive Chairman, Chief Executive Officer and President

Board

DirectorRole
Henry JiExecutive Chairman, Chief Executive Officer and President
Alexander WuDirector
Dorman Followwill+Director
Jay ChunDirector

Decks

DeckKindSlidesDate
SPAC Merger (September 2024)SPAC merger23 slidesSeptember 2024
SPAC Merger (September 2024)SPAC merger24 slidesSeptember 2024
SPAC Merger (August 2024)SPAC merger20 slidesAugust 2024
Investor Presentation (August 2024)Investor deck25 slidesAug 1, 2024
Investor Presentation (August 2024)Investor deck25 slidesAugust 2024
SPAC Merger (August 2024)SPAC merger23 slidesAugust 2024
Investor Presentation (August 2024)Investor deck23 slidesAugust 2024
Investor Presentation (August 2024)Investor deck31 slidesAugust 2024
SPAC Merger (August 2024)SPAC merger22 slidesAugust 2024

Open Decks

IPO

Went public as Denali Capital Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Apr 6, 2022.

Price
US$10.00 a unit
Units offered
7,500,000 units
Offering size
US$75 million
Underwriters' option
Up to 1,125,000 more units
Listing
DECAU on the Nasdaq Global Market
Underwriters
Tiger Brokers, EF Hutton · In the order on the cover
Units delivered
On or about Apr 11, 2022

Steps

StepWhen
Filed publiclyMar 1, 2022
Amended 3 timesNewest Apr 5, 2022
Shares registered with an exchangeApr 6, 2022
Declared effective by the SECApr 6, 2022
Final prospectus, with the priceApr 7, 2022

Open IPO · From the cover of the final prospectus (424B3) filed Apr 7, 2022

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Research and development2.55M1.71M
Operating income-160.4M-4.69M-3.17M
Depreciation and amortization00
EBITDA-160.4M-4.69M
Interest expense96.2K36.9K
Income before tax00
Income tax00
Net income-160.4M-4.69M632.5K-419.4K
Earnings per share, basic-0.78-0.020.00
Earnings per share, diluted-0.78-0.02

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents20.0K12.0K204.5K819.7K
Current assets596.0K6.00M209.4K907.8K
Property, plant and equipment750.0K689.0K
Total assets1.35M6.68M50.7M86.3M
Accounts payable5.91M0
Current liabilities10.2M35.0K5.60M1.29M
Total liabilities22.1M49.5M8.49M4.18M
Shareholders' equity-20.8M-42.8M-38.1M-3.27M
Shares outstanding230.2M200.0M230.2M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-5.87M-4.89M-632.8K-426.1K
Cash from investing43.4M39.7M-84.2M
Cash from financing5.88M4.89M-39.7M85.4M
Share buybacks-43.4M-40.5M
Change in cash8.00K0-615.3K819.7K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
10-Q · Quarterly reportAug 10, 2026Quarterly reportSEC
424B3 · ProspectusJul 7, 2026Offer documentSEC
8-K · Current reportJul 7, 2026Material contractSEC
424B3 · ProspectusJul 1, 2026Offer documentSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 26, 2026Big-stake noticeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
8-K · Current reportJun 25, 2026Meeting outcomeSEC
424B3 · ProspectusJun 15, 2026Offer documentSEC
424B3 · ProspectusJun 15, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
EFFECT · Notice that a registration is effectiveMay 19, 2026Other filingsSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
POS AM · Amendment to an effective registrationMay 12, 2026Offer documentSEC
ARS · Annual report to shareholdersApr 30, 2026Annual reportSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
8-K · Current reportApr 23, 2026Current reportSEC
8-K · Current reportMar 17, 2026Management or board changeSEC
10-K · Annual reportFeb 27, 2026Annual reportSEC
EFFECT · Notice that a registration is effectiveDec 30, 2025Other filingsSEC
424B3 · ProspectusDec 29, 2025Offer documentSEC
CORRESP · Letter to the SECDec 23, 2025Other filingsSEC
S-1/A · Registration statement, amendedDec 19, 2025Offer documentSEC
S-8 · Registration statement for employee plansDec 3, 2025Offer documentSEC
S-8 · Registration statement for employee plansDec 3, 2025Offer documentSEC
8-K · Current reportDec 3, 2025Current reportSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
S-1 · Registration statementOct 21, 2025Offer documentSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 14, 2025Big-stake noticeSEC
3 · Initial statement of ownershipSep 26, 2025Insider tradeSEC
8-K · Current reportSep 26, 2025Acquisition or disposalSEC
4 · Change in ownershipSep 25, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
8-K · Current reportSep 3, 2025Meeting outcomeSEC
DEFA14A · Additional proxy materialAug 21, 2025Meeting noticeSEC
425Aug 21, 2025Other filingsSEC
8-K · Current reportAug 21, 2025Material contractSEC
10-Q · Quarterly reportAug 15, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
NT 10-Q · Late filing noticeAug 14, 2025Explanation requestSEC
EFFECT · Notice that a registration is effectiveAug 13, 2025Other filingsSEC
424B3 · ProspectusAug 12, 2025Offer documentSEC
S-4/A · Registration statement, amendedAug 12, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
CORRESP · Letter to the SECAug 11, 2025Other filingsSEC
425Aug 11, 2025Other filingsSEC
8-K · Current reportAug 11, 2025Current reportSEC
S-4/A · Registration statement, amendedAug 11, 2025Offer documentSEC
CORRESP · Letter to the SECAug 8, 2025Other filingsSEC
S-4/A · Registration statement, amendedAug 8, 2025Offer documentSEC
UPLOAD · Letter from the SECAug 7, 2025Other filingsSEC
425Jul 28, 2025Other filingsSEC
8-K · Current reportJul 28, 2025Material contractSEC
CORRESP · Letter to the SECJul 23, 2025Other filingsSEC
S-4/A · Registration statement, amendedJul 23, 2025Offer documentSEC
UPLOAD · Letter from the SECJul 16, 2025Other filingsSEC
25-NSEJul 14, 2025Other filingsSEC
425Jul 11, 2025Other filingsSEC
8-K · Current reportJul 11, 2025Current reportSEC
CORRESP · Letter to the SECJul 2, 2025Other filingsSEC
S-4/A · Registration statement, amendedJul 2, 2025Offer documentSEC
UPLOAD · Letter from the SECJun 26, 2025Other filingsSEC
8-K · Current reportJun 11, 2025Current reportSEC
CORRESP · Letter to the SECJun 11, 2025Other filingsSEC
S-4/A · Registration statement, amendedJun 11, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedJun 5, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECMay 20, 2025Other filingsSEC
10-Q · Quarterly reportMay 16, 2025Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2025Explanation requestSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
425May 9, 2025Other filingsSEC
8-K · Current reportMay 9, 2025Current reportSEC
8-K · Current reportApr 22, 2025Material contractSEC
CORRESP · Letter to the SECApr 21, 2025Other filingsSEC
S-4/A · Registration statement, amendedApr 21, 2025Offer documentSEC
8-K · Current reportApr 15, 2025Meeting outcomeSEC
425Apr 8, 2025Other filingsSEC
8-K · Current reportApr 8, 2025Current reportSEC
10-K · Annual reportApr 1, 2025Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2025Explanation requestSEC
UPLOAD · Letter from the SECMar 28, 2025Other filingsSEC
DEF 14A · Proxy statementMar 27, 2025Meeting noticeSEC
CORRESP · Letter to the SECMar 25, 2025Other filingsSEC
PRER14AMar 25, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 25, 2025Other filingsSEC
PRE 14A · Preliminary proxy statementMar 20, 2025Meeting noticeSEC
425Mar 11, 2025Other filingsSEC
8-K · Current reportMar 11, 2025Current reportSEC
425Feb 11, 2025Other filingsSEC
8-K · Current reportFeb 11, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 7, 2025Big-stake noticeSEC
425Jan 8, 2025Other filingsSEC
8-K · Current reportJan 8, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeDec 26, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECDec 12, 2024Other filingsSEC
425Dec 11, 2024Other filingsSEC
8-K · Current reportDec 11, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedDec 6, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 19, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
NT 10-Q · Late filing noticeNov 14, 2024Explanation requestSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
425Nov 12, 2024Other filingsSEC
8-K · Current reportNov 12, 2024Current reportSEC
S-4 · Registration statementNov 6, 2024Offer documentSEC
425Oct 11, 2024Other filingsSEC
8-K · Current reportOct 11, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedOct 7, 2024Big-stake noticeSEC
425Oct 7, 2024Other filingsSEC
8-K · Current reportOct 7, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedSep 16, 2024Big-stake noticeSEC
4 · Change in ownershipSep 16, 2024Insider tradeSEC
4 · Change in ownershipSep 16, 2024Insider tradeSEC
425Sep 11, 2024Other filingsSEC
8-K · Current reportSep 11, 2024Current reportSEC
SC 13D · Big-stake noticeSep 9, 2024Big-stake noticeSEC
425Sep 4, 2024Other filingsSEC
8-K · Current reportSep 4, 2024Material contractSEC
10-Q · Quarterly reportAug 19, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2024Explanation requestSEC
425Aug 9, 2024Other filingsSEC
8-K · Current reportAug 9, 2024Material contractSEC
SC 13G · Big-stake noticeAug 9, 2024Big-stake noticeSEC
8-K · Current reportJul 17, 2024Current reportSEC
425Jul 10, 2024Other filingsSEC
8-K · Current reportJul 10, 2024Material contractSEC
8-K · Current reportJul 5, 2024Current reportSEC
DEF 14A · Proxy statementJun 28, 2024Meeting noticeSEC
8-K · Current reportJun 27, 2024Current reportSEC
PRE 14A · Preliminary proxy statementJun 18, 2024Meeting noticeSEC
10-Q · Quarterly reportMay 21, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2024Explanation requestSEC
10-K · Annual reportApr 1, 2024Annual reportSEC
8-K · Current reportFeb 27, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 22, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 2, 2024Big-stake noticeSEC
8-K · Current reportJan 9, 2024Meeting outcomeSEC
425Dec 29, 2023Other filingsSEC
DEFA14A · Additional proxy materialDec 29, 2023Meeting noticeSEC
425Dec 29, 2023Other filingsSEC
8-K · Current reportDec 29, 2023Current reportSEC
DEFM14ADec 15, 2023Meeting noticeSEC
425Nov 20, 2023Other filingsSEC
8-K · Current reportNov 20, 2023Material contractSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
SC 13G · Big-stake noticeNov 7, 2023Big-stake noticeSEC
425Oct 11, 2023Other filingsSEC
8-K · Current reportOct 11, 2023Material contractSEC
DEFR14ASep 27, 2023Meeting noticeSEC
DEF 14A · Proxy statementSep 25, 2023Meeting noticeSEC
PRE 14A · Preliminary proxy statementSep 11, 2023Meeting noticeSEC
425Aug 30, 2023Other filingsSEC
425Aug 30, 2023Other filingsSEC
8-K · Current reportAug 30, 2023Current reportSEC
425Aug 25, 2023Other filingsSEC
8-K · Current reportAug 25, 2023Material contractSEC
10-Q · Quarterly reportAug 15, 2023Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2023Explanation requestSEC
425Aug 4, 2023Other filingsSEC
425Aug 4, 2023Other filingsSEC
8-K · Current reportAug 4, 2023Current reportSEC
425Jul 13, 2023Other filingsSEC
8-K · Current reportJul 13, 2023Material contractSEC
SC 13G · Big-stake noticeMay 16, 2023Big-stake noticeSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
425Apr 12, 2023Other filingsSEC
425Apr 12, 2023Other filingsSEC
8-K · Current reportApr 12, 2023Material contractSEC
10-K · Annual reportMar 17, 2023Annual reportSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 10, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 10, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 7, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 31, 2023Big-stake noticeSEC
425Jan 26, 2023Other filingsSEC
8-K/A · Current report, amendedJan 26, 2023Material contractSEC
8-K · Current reportJan 26, 2023Material contractSEC
10-Q · Quarterly reportNov 15, 2022Quarterly reportSEC
NT 10-Q · Late filing noticeNov 14, 2022Explanation requestSEC
SC 13G · Big-stake noticeOct 20, 2022Big-stake noticeSEC
8-K · Current reportOct 19, 2022Current reportSEC
10-Q · Quarterly reportAug 12, 2022Quarterly reportSEC
8-K · Current reportMay 27, 2022Current reportSEC
4 · Change in ownershipMay 24, 2022Insider tradeSEC
4 · Change in ownershipMay 24, 2022Insider tradeSEC
10-Q · Quarterly reportMay 23, 2022Quarterly reportSEC
8-K · Current reportApr 15, 2022Current reportSEC

This page holds 200 of 221 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Shareholders

HolderSharesOf the companyValueChange vs Jun 30Filed
Transce3nd, LLC500<0.01%US$188NewOct 26, 2026
Rhumbline Advisers35<0.01%US$18NewNov 10, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kevin Vassily
Other companies: CTW (Director · Since at least Apr 1, 2026); Tungray Technologies Inc (Director · Since at least Mar 18, 2026); Zhongchao Inc. (Director · Since at least Mar 18, 2026); Thunder Power Holdings, Inc. (Independent Director · Since at least Jun 15, 2022); iPower Inc. (Chief Financial Officer, Director · May 12, 2021 – Jun 1, 2023 · Past)
Director · Apr 6, 2022 – Apr 6, 2022 · Past
Jaisim Shah
Other companies: Scilex Holding Company (See Remarks, Director · Nov 10, 2022 – Dec 18, 2024 · Past); Sorrento Therapeutics, Inc. (Director · Sep 9, 2013 – Aug 30, 2021 · Past); Facet Biotech Corp (SVP, Chief Business Officer · Dec 9, 2008 – Dec 9, 2008 · Past); PDL BioPharma Inc (SVP, Mktg & Bus. Affairs · Jan 9, 2006 – Apr 28, 2008 · Past)
See Remarks, Director · Since at least Sep 22, 2025
Henry Ji
Other companies: Scilex Holding Company (Executive Chairman, Chief Executive Officer and President · Since at least Nov 10, 2022); Sorrento Therapeutics, Inc. (Chairman, President and CEO · Since at least Feb 16, 2010); ImmunityBio, Inc. (Director · Jul 27, 2015 – Jul 27, 2015 · Past)
Executive Chairman, Chief Executive Officer and President · Since at least Sep 22, 2025
Dorman Followwill
Other companies: Scilex Holding Company (Director · Since at least Nov 10, 2022); Sorrento Therapeutics, Inc. (Director · Sep 26, 2017 – Aug 30, 2021 · Past)
Director · Since at least Sep 22, 2025
Yue Alexander Wu
Other companies: Scilex Holding Company (Director · Since at least Sep 22, 2023); Sorrento Therapeutics, Inc. (Director · Aug 1, 2016 – Aug 30, 2021 · Past)
Director · Since at least Sep 22, 2025
Alexander Wu
Other companies: Scilex Holding Company (Director · Since at least Nov 5, 2026)
Director · Since at least Nov 5, 2026
Annu Navani
Other companies: Scilex Holding Company (Director · Jul 21, 2024 – Aug 16, 2024 · Past)
Director · Since at least Sep 22, 2025
Huifeng Chang
Other companies: Scienjoy Holding Corporation (Independent Director · Since at least May 7, 2020)
Director · Apr 6, 2022 – Apr 6, 2022 · Past
Jay Chun
Other companies: Scilex Holding Company (Director · Since at least Sep 22, 2023)
Director · Since at least Sep 22, 2025
Lei Huang
Other companies: SAIHEAT Limited (Co-Chief Executive Officer · Apr 28, 2021 – Apr 28, 2021 · Past)
Chief Executive Officer, Director · Apr 6, 2022 – Apr 6, 2022 · Past
All 13 people
PersonSeat
Stephen Hoi
Other companies: Scilex Holding Company (CFO, COO and Secretary, Director · Since at least Sep 22, 2023)
See Remarks · Since at least Sep 22, 2025
Jim MaoDirector · Apr 6, 2022 – Apr 6, 2022 · Past
You SunChief Financial Officer · Apr 6, 2022 – Apr 6, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Semnur Pharmaceuticals, Inc.